Drawing for ARGO

USPTO serial 50017199

ARGO

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
JUN, WON KYUNG WENDY
Law office
TMO LAW OFFICE 131

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hillary I. Schroeder

Hillary I. Schroeder Name Game IP, PC8605 Santa Monica Blvd., #145444West Hollywood, CA 90069United States

Goods and services

ClassDescriptionStatusFirst use
001Assays for research purposes; Assays for scientific use; Reagents for research purposes; Reagents for scientific purposesACTIVE—
005Diagnostic agents, preparations and substances for medical use; Medical diagnostic assays for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical diagnostic assays for detecting proteins and proteomic changes; Medical diagnostic assays for analyzing proteins and proteomic changes; Medical diagnostic assays for testing body fluids; Medical diagnostic assays for detecting neurological disease; Medical diagnostic assays for analyzing neurological disease; Medical diagnostic assays for detecting autoimmune and inflammatory disorders; Medical diagnostic assays for analyzing autoimmune and inflammatory disorders; Medical diagnostic assays for detecting respiratory disease; Medical diagnostic assays for analyzing respiratory disease; Medical diagnostic assays for detecting progression of cancer; Medical diagnostic assays for analyzing progression of cancer; Medical diagnostic assays for analyzing potential cancer treatmentsACTIVE—
010Medical diagnostic apparatus for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical diagnostic apparatus for detecting proteins and proteomic changes; Medical diagnostic apparatus for detecting presence and progression of neurological disease; Medical diagnostic apparatus for detecting presence and progression of autoimmune and inflammatory disorders; Medical diagnostic apparatus for detecting presence and progression of respiratory disease; Medical diagnostic apparatus for detecting presence and progression of infectious disease; Medical diagnostic apparatus for detecting presence and progression of cancer; Genetic testing apparatus for medical purposes; Apparatus for blood analysisACTIVE—
042Scientific research and development; Providing scientific research information; Scientific research in the field of genetics; Scientific research consulting in the field of proteomics; Genetic testing for scientific research purposes; Blood analysis for scientific research purposes; Blood testing for scientific research purposes; Providing temporary use of online non-downloadable computer software for analysis of biological data; Providing temporary use of online non-downloadable computer software for analysis of proteomics dataACTIVE—
044Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 27, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Oct 27, 2026CNSLSUSPENSION LETTER WRITTEN—
Oct 27, 2026DOCKASSIGNED TO EXAMINER—
Sep 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 28, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance